New startup to test psychedelic-like drug for Parkinson's symptom

A new startup is planning clinical trials of a psychedelic-like compound targeting a Parkinson's disease symptom. The drug's efficacy and safety in humans remain unproven, and the development is at an early stage. This is notable for the biotech sector but not yet a major market event.